Oregon 2023 Regular Session

Oregon Senate Bill SB716

Introduced
1/9/23  
Refer
1/13/23  

Caption

Relating to off-label indications for prescription drugs; prescribing an effective date.

Impact

The bill could significantly alter state laws regarding the prescribing of medications. By formalizing the practices surrounding off-label prescribing, it is intended to enhance healthcare delivery while ensuring that physicians are protected legally when opting to use their clinical judgment. This change aims to improve patient outcomes, particularly for those with conditions that may not have extensive treatment options available through approved drug labels.

Summary

SB716 addresses the issue of off-label indications for prescription drugs, aiming to establish guidelines around their prescribing. The bill recognizes the clinical practice where physicians prescribe medications for uses that are not specifically approved by regulatory agencies. By proposing a framework for off-label use, SB716 seeks to clarify the legal and ethical parameters that medical practitioners must navigate, ultimately ensuring that patients receive appropriate care for conditions that existing medications can address even if not formally recognized for those indications.

Sentiment

The general sentiment surrounding SB716 appears to be cautiously optimistic. Healthcare professionals recognize the necessity for clarity in prescribing practices, especially in complex cases where off-label use may be the best option for patient treatment. However, concerns have been raised regarding the potential risks involved, including the possibility of misuse or over-reliance on off-label prescriptions without sufficient regulatory oversight.

Contention

Notable points of contention include debates regarding the adequacy of the proposed guidelines to safeguard against misuse of off-label prescribing. Critics emphasize the importance of ensuring that patients are fully informed about the risks and benefits when off-label medications are prescribed. Additionally, discussions have centered on whether the bill offers enough protections for both patients and healthcare providers, highlighting the need for a balanced approach that promotes innovation in treatment while maintaining rigorous safety standards.

Companion Bills

No companion bills found.

Previously Filed As

OR HB2057

Relating to prescription drugs; prescribing an effective date.

OR HB855

Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.

OR SB1986

Relating to warning labels for opioid prescription drugs.

OR HB1430

Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.

OR HB0164

Medical prescriptions-off-label purposes.

OR HB3046

Relating to pharmacy; prescribing an effective date.

OR HB3223

Relating to prescription drugs; prescribing an effective date.

OR HB3367

Compound prescriptions; electronic prescriptions; effective date.

OR SB90

Relating to patient access to prescription drugs for off-label use.

OR HB3226

Relating to organizations that provide services related to obtaining prescription drugs; and prescribing an effective date.

Similar Bills

FL H1297

Electronic Prescribing

NJ A2766

Establishes deadline for DEP implementation of prescribed burn program, and provides for establishment of prescribed burn acreage goals, schedules, calendars, training program, and mobile deployment units to provide on-site prescribed burn training and assistance.

AZ SB1125

Psychologists; prescribing authority

IN HB1557

Prescribed burning.

TX SB2510

Relating to establishment of the temporary prescribed burn manager self-insurance pool; authorizing a fee.

IL HB2514

PRESCRIBED BURNING-LIABILITY

WV SB886

Permitting prescribed fire control on private property without burning permit

WA SB5112

Establishing a prescribing psychologist certification in Washington state.